Kampala, Uganda | THE INDEPENDENT | The Uganda Virus Research Institute-UVRI is to start a new trial aimed at reducing the dosage of the yellow fever vaccine. During the trial, a fifth of the yellow fever dosage 0.1 millilitres will be given to participants. The global recommended dose of yellow …
Read More »Uganda to start Ebola vaccine trials
Kampala, Uganda | THE INDEPENDENT | The Uganda Virus Research Institute-UVRI is set to carry out phase two human trials for the Ebola vaccine. The trials are expected to start in July. The trial is going to use the Janssen Ebola Vaccine that was developed by Janssen Pharmaceutical Company. Phase I and …
Read More »